Moderna, Inc. (0QF.F)

EUR 24.53

(10.37%)

Total Assets Summary of Moderna, Inc.

Moderna, Inc.'s latest annual total assets in 2023 was 18.42 Billion USD , down -28.74% from previous year.
Moderna, Inc.'s latest quarterly total assets in 2024 Q2 was 15.68 Billion USD , down -6.27% from previous quarter.
Moderna, Inc. reported annual total assets of 25.85 Billion USD in 2022, up 4.82% from previous year.
Moderna, Inc. reported annual total assets of 24.66 Billion USD in 2021, up 236.24% from previous year.
Moderna, Inc. reported quarterly total assets of 15.68 Billion USD for 2024 Q2, down -6.27% from previous quarter.
Moderna, Inc. reported quarterly total assets of 24.12 Billion USD for 2023 Q1, down -6.7% from previous quarter.

Annual Total Assets Chart of Moderna, Inc. (2023 - 2016)

Historical Annual Total Assets of Moderna, Inc. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	18.42 Billion USD	-28.74%
2022	25.85 Billion USD	4.82%
2021	24.66 Billion USD	236.24%
2020	7.33 Billion USD	361.6%
2019	1.58 Billion USD	-19.0%
2018	1.96 Billion USD	80.93%
2017	1.08 Billion USD	-23.47%
2016	1.41 Billion USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	16.72 Billion USD	-9.21%
2024 Q2	15.68 Billion USD	-6.27%
2023 Q1	24.12 Billion USD	-6.7%
2023 Q3	19.45 Billion USD	-11.12%
2023 Q2	21.88 Billion USD	-9.29%
2023 FY	18.42 Billion USD	-28.74%
2023 Q4	18.42 Billion USD	-5.26%
2022 Q4	25.85 Billion USD	-0.76%
2022 Q3	26.05 Billion USD	0.05%
2022 Q2	26.04 Billion USD	-5.67%
2022 FY	25.85 Billion USD	4.82%
2022 Q1	27.6 Billion USD	11.92%
2021 Q1	12.69 Billion USD	73.02%
2021 Q3	20.92 Billion USD	29.53%
2021 Q4	24.66 Billion USD	17.9%
2021 FY	24.66 Billion USD	236.24%
2021 Q2	16.15 Billion USD	27.25%
2020 Q4	7.33 Billion USD	57.75%
2020 Q2	3.48 Billion USD	68.61%
2020 Q1	2.06 Billion USD	30.08%
2020 FY	7.33 Billion USD	361.6%
2020 Q3	4.65 Billion USD	33.42%
2019 Q2	1.68 Billion USD	-6.7%
2019 FY	1.58 Billion USD	-19.0%
2019 Q4	1.58 Billion USD	-0.09%
2019 Q3	1.59 Billion USD	-5.6%
2019 Q1	1.8 Billion USD	-7.95%
2018 Q3	1.48 Billion USD	0.0%
2018 FY	1.96 Billion USD	80.93%
2018 Q4	1.96 Billion USD	31.76%
2017 Q4	1.08 Billion USD	0.0%
2017 FY	1.08 Billion USD	-23.47%
2016 FY	1.41 Billion USD	0.0%

Peer Total Assets Comparison of Moderna, Inc.

Name	Total Assets	Total Assets Difference
BioNTech SE	23 Billion EUR	19.909%
CureVac N.V.	788.89 Million EUR	-2235.661%
Biotest Aktiengesellschaft	1.44 Billion EUR	-1175.774%
Biotest Aktiengesellschaft	1.44 Billion EUR	-1175.774%
BRAIN Biotech AG	70.93 Million EUR	-25875.161%
Formycon AG	890.36 Million EUR	-1969.495%
Heidelberg Pharma AG	70.35 Million EUR	-26090.769%
Medigene AG	31.71 Million EUR	-57996.86%